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ReviewTranscription: Tantalizing Times
for T Cells
bacteria such as Listeria monocytogenes. CD4 and CD8
cells arise from a common lymphoid progenitor cell in
the thymus. In addition to this cell-mediated series of
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Boston, Massachusetts 02115 signal to B lymphocytes to produce antibodies. Type 2
immunity is particularly important to neutralize certain2 Department of Medicine
Harvard Medical School viruses and to ward off parasites. It is now clear that
type 1 and type 2 immunity are actually directed by twoBoston, Massachusetts 02115
distinct subsets of T helper lymphocytes as described
below.
The T helper lymphocyte is responsible for orchestrat-
ing an appropriate immune response to pathogens. Overview of Transcriptional Regulation
To do so, it has evolved into two specialized subsets of Th Cell Differentiation
that direct type 1 and type 2 immunity. Here, we dis- Two distinct functional subsets of CD4Th cells were
cuss the genetic programs that control lineage com- identified more than a decade ago (Mosmann et al.,
mitment of progenitor T helper cells along each of 1986; Mosmann and Coffman, 1989). Type 1 Th (Th1)
these pathways. cells secrete IFN-, TNF-, and LT, which are responsi-
ble for delayed type hypersensitivity responses. Con-
The versatility of the T lymphocyte has made it an attrac- versely, type 2 Th (Th2) cells produce IL-4, IL-5, IL-10,
tive system in which to study cell differentiation and and IL-13, and are responsible for providing help to
lineage commitment. The attention it has received from B cells, enhancing maturation and chemoattraction of
the immunologic community over the last several years eosinophils, and mounting allergic responses (Mos-
has happily resulted in significant advances in this field. mann and Coffman, 1989; Paul and Seder, 1994). The
Several subset-specific transcription factors and sur- hallmark cytokine of the Th1 cell is IFN- and of the Th2
face molecules have been isolated, and novel signaling cell, IL-4. In addition to distinct cytokine profiles, several
pathways identified. The generation and analysis of ge- surface markers have been shown to be differentially
netically engineered mice has not only allowed the con- expressed in Th cells. For example, the IL-12 receptor
firmation of results of in vitro experiments, but has also (IL-12R) 2 chain, chemokine receptors CXCR3 and
yielded unexpected findings that led to new discoveries. CCR5, and IL-18 receptor are found mainly on Th1 cells,
Indeed, several reviews on this topic have been recently while T1/ST2, CCR3, CCR4 and ICOS molecules are
published, and readers are referred to these reviews for enriched on the surface of Th2 cells (Bonecchi et al.,
details (Glimcher and Murphy, 2000; Murphy et al., 2000; 1998; D’Ambrosio et al., 1998; Lohning et al., 1998; Mc-
Dong and Flavell, 2000; O’Garra and Arai, 2000). Here, Adam et al., 2000; Sallusto et al., 1998; Szabo et al.,
we will focus our discussion on events that are taking 1997; Xu et al., 1998). The balance between the Th1/Th2
place in the nucleus of the T helper (Th) lymphocyte, in subsets determines the type of response, and ultimately,
particular the transcription factors that control its differ- the outcome of that response for an individual organism
entiation from an uncommitted precursor cell to a spe- to any given pathogen be it an infectious agent, tumor
cialized effector cell. Rather than reiterating previous antigen, organ graft, allergen or autoantigen.
reviews on the same topic, we will try to summarize Despite functional and phenotypic differences, both
recent discoveries in this field and emphasize the critical subsets of Th cells are derived from the same precursor
questions that remain to be answered. Th (Thp) cell (Kamogawa et al., 1993). The fate of differ-
entiating Th cells can be influenced by multiple factors,
Overview of T Cell Differentiation which include cytokine milieu, type of antigen presenting
An effective immune response against pathogens, be cell, type and delivery route of antigens, and mode of
they microbial agents, allergens, tumor antigens or au- costimulation (Figure 2) (Constant and Bottomly, 1997;
toantigens, must be of both appropriate magnitude and Lane, 2000; Liu et al., 2001; O’Garra, 1998; Salomon and
type (Figure 1). Type 1 immunity relies on differentiation Bluestone, 2001; Sperling and Bluestone, 2001). While
of one major subset of T lymphocytes, the T helper cell, an increasing number of extracellular factors and signal-
bearing the surface receptor CD4, that induces both ing pathways have been discovered to affect the differ-
inflammatory and cytotoxic responses essential for de- entiation of Th cells, it is believed that it is the cytokine
struction of intracellular pathogens such as Mycobacte- milieu itself that primarily determines this fate. The cyto-
rium tuberculosis and Leishmania Major. The T helper kine milieu is critical for both the initiation and the expan-
lymphocyte activates macrophages and also activates sion of the Th1 and Th2 subsets. Mice that lack IFN-,
a second major type of T cell, the CD8 cytotoxic T cell, IL-12 or their receptors, or the Stat signaling molecule
which is critical for the effective handling of microbial Stat4 downstream of the IL-12 receptor, fail to develop
agents such as the human immunodeficiency virus, and a robust Th1 compartment while mice that lack IL-4, IL-
4R or Stat6 have severely compromised Th2 develop-
ment (Gessner and Rollinghoff, 2000; Magram et al.,3 Correspondence: lglimche@hsph.harvard.edu
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and IL-4 gene-specific activator (Ho et al., 1996; Kim et
al., 1999). In synergy with other transcription factors
or coactivators, such as NFAT and NIP45, c-Maf and
GATA-3 control the expression of IL-4, which further
reinforces the IL-4R/Stat6 signal.
Conversely, if a Thp cell is stimulated in the presence
of IL-12 and IFN-, and antibody against IL-4, IFN-
signals through the IFN- receptor activate Stat1 which
leads to upregulation of the expression of the Th1 cell-
specific transcription factor, T-bet (Lighvani et al., 2001).
T-bet is a potent transactivator of the IFN- gene and
was recently demonstrated to be the master regulator
of Th1 lineage commitment (Szabo et al., 2000, 2002).
The expression of T-bet is followed by secretion of IFN-
and upregulation of the IL-12R2 chain, which further
strengthens the IFN- and IL-12 signals (Szabo et al.,
1997; Mullen et al., 2001). Overall these experiments
highlight the critical role of the cytokine milieu in de-Figure 1. T Cell Differentiation
termining lineage commitment, and support the idea
that transcription factors that control the subset-spe-
1996; Piccotti et al., 1998; Wurster et al., 2000; Zhang cific cytokines IFN- and IL-4, will also control lineage
et al., 2001). Two other polypeptide mediators, Eta1 (os- commitment. This has indeed turned out to be the case
teopontin) and the chemokine MCP-1, also influence Th for the tissue-specific factors that have been isolated
differentiation as demonstrated by the impairment in to date.
Th1 and Th2 compartments, respectively, observed in This review will therefore focus primarily on what we
mice lacking these genes (Ashkar et al., 2000; Gu et al., have learned, and what remains to be learned, about
2000). The factors downstream of Eta-1 and MCP-1 that the transcriptional control of Th cell differentiation. A
accomplish this, however, are unknown. brief summary of the three subset-specific, functionally
In contrast, recent studies demonstrate that the cyto- important, transcription factors isolated to date is pro-
kines, IFN-, and IL-4, exert their effects through control- vided first.
ling the expression of subset-specific transcription fac-
tors in a bidirectional, positive feedback loop. For
example, when a Thp cell is stimulated in the presence T-bet
T-bet, a novel member of the T-box family of transcrip-of IL-4 and antibodies against IL-12 or IFN-, the IL-4
signaling factor Stat6 is activated, translocates into the tion factors, was originally cloned both by virtue of its
ability to bind to the Th1-specific IL-2 promoter in anucleus, and rapidly induces (either directly or indirectly)
the expression of GATA-3 (Ouyang et al., 1998; Kurata yeast one hybrid screen, and by its expression in Th1
but not Th2 cells (Szabo et al., 2000). Overexpressionet al., 1999), a Th2 cell-specific transcription factor that
is a master regulator of the Th2 differentiation pathway of T-bet by retroviral gene transduction in primary T cells
forces uncommitted Thp cells, differentiating Th2 cells(Ouyang et al., 1998; Zhang et al., 1997; Zheng and
Flavell, 1997). The expression of GATA-3 is followed and most remarkably, terminally committed, fully polar-
ized Th2 cells to display a Th1 cell phenotype, includingby the induction of the transcription factor c-Maf, also
preferentially expressed in Th2 cells, that is a potent production of IFN- and repression of the Th2 cytokines
Figure 2. Signals that Influence Th Cell Differentiation
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IL4 and IL-5. T-bet expression correlates with IFN- ex- GATA-3 undergoes a process of autoactivation to aug-
ment its own expression in a Stat6-independent mannerpression, and T-bet can transactivate the IFN- gene
and induce both endogenous IFN- production, upregu- (Ouyang et al., 2000). Several in vitro studies have clearly
demonstrated that GATA-3 is sufficient, although notlation of IL-12R2 chain, and chromatin remodeling of
individual IFN- alleles (Mullen et al., 2001; Szabo et al., very potent, in directing developing and polarized Th
cells to produce Th2 cytokines (Lee et al., 2000; Ouyang2000). Thus, T-bet likely activates Th1 genetic programs
in part through directly controlling IFN- gene transcrip- et al., 1998).
Unfortunately, GATA-3 deficiency in the lymphoid sys-tion. The in vitro functions of T-bet were confirmed by
in vivo studies of genetically altered mice lacking T-bet. tem results in a complete block in the very early stages
of T cell development, thus precluding a definitive testT-bet-deficient (T-bet/) mice had normal lymphoid de-
velopment but exhibited profound defects in mounting of its role in Th2 differentiation. However, strong support
for its critical role here is provided by several recentTh1 immune responses (Szabo et al., 2002). T-bet/ Th
and NK cells produced severely reduced amounts of reports. Despite the essential function of Stat6 in dictat-
ing the differentiation of Th2 cells in vitro, Th2 immuneIFN-; and T-bet deficiency rendered resistant C57BL/6
mice susceptible to Leishmania major infection. A corre- responses can still be elicited in Stat6-deficient
(Stat6/) animals whose Th2 cells continue to expresssponding increase in Th2 cytokines was present.
The balance between Th1 and Th2 subsets is critical high levels of GATA-3 (Finkelman et al., 2000; Jankovic
et al., 2000; Ouyang et al., 2000). Transgenic mice over-in the immune response to pathogens, autoantigens,
tumor antigens and allergens. Most autoimmune dis- expressing a dominant negative mutant of GATA-3,
KRR, are more resistant to allergic asthma, a classicaleases arise from pathogenic Th1 cells while asthma and
allergic responses reflect an overabundance of disease- Th2 cell-mediated disease (Zhang et al., 1999). Th2 cells
derived from these animals expressed significantlycausing Th2 cells. Given T-bet’s role in controlling the
Th1/Th2 balance, its function was assessed in several lower levels of Th2 cytokines upon rechallenge with anti-
gens. More recently, Finotto et al. demonstrated thatmouse models of human disease. Absence of T-bet was
protective in inflammatory bowel disease mouse models addition of GATA-3 antisense oligonucleotides during
in vitro differentiation of Th2 cells significantly reduced(Neurath et al., 2002). Reciprocal effects of T-bet defi-
ciency were seen in allergic asthma. The number of the levels of GATA-3 protein and subsequent production
of IL-4 (Finotto et al., 2002). In addition, local administra-T-bet-expressing cells was substantially reduced in the
airways of asthmatic patients (Finotto et al., 2002). tion of GATA-3 antisense oligonucleotides markedly at-
tenuated airway hyperresponsiveness, mucus produc-T-bet/ mice developed spontaneous airway hyperre-
sponsiveness, airway inflammation and airway remodel- tion, and infiltration of eosinophils in an animal model
of allergic asthma. These results strongly indicate thating, features of acute and chronic asthma that resem-
bled human asthma, and these pathological changes GATA-3 is essential for the development of Th2 cells
and might also be essential to maintain Th2 phenotypecould be adoptively transferred with T-bet/ Th cells
(Finotto et al., 2002). The effects of T-bet may be ex- and function. The mechanism by which GATA-3 controls
Th2 cytokine gene expression is still unclear and mayplained both by an alteration of the Th1/Th2 balance,
and by reciprocal regulation of IFN- and the immuno- differ for each of the Th2 cytokines. Thus, GATA-3 can
bind to and directly transactivate the IL-5 and IL-13suppressive cytokine TGF- by T-bet (Neurath et al.,
2002). Taken together, these studies firmly establish regulatory regions, but has only a minimal effect on the
IL-4 promoter (Kishikawa et al., 2001; Lee et al., 1998;T-bet as a transcription factor required for Th1 lineage
commitment. While T-bet is the only Th1-specific tran- Siegel et al., 1995; Zhang et al., 1997).
scription factor isolated to date, there are certainly addi-
tional transcription factors, most notably NF-B, that c-Maf
contribute to IFN- production as demonstrated most c-Maf is a basic-leucine zipper protein that binds to a
convincingly by the impairment in the production of this TRE/CRE-like sequence called MARE or C-MARE (Ka-
cytokine in mice expressing a dominant-negative IB taoka et al., 1994; Kerppola and Curran, 1994). c-Maf is
transgene (Aronica et al., 1999) preferentially expressed in Th2 cells and is also ex-
pressed at very low levels in naive Th cells (Ho et al.,
1996). In contrast to the rapid induction of GATA-3 andGATA-3
GATA-3, a member of the GATA family of zinc finger T-bet by cytokines, the induction of c-Maf by TCR signal-
ing occurs only after two days of initial stimulation underproteins, was originally cloned as a T cell-specific tran-
scription factor that bound to the enhancer of the T cell Th2 skewing conditions, and the levels of c-Maf can be
further and rapidly induced in mature Th2 cells uponreceptor (TCR)  gene (Ho et al., 1991). Indeed, GATA-3
is essential for the development of T cell lineage (Hen- restimulation. Further, unlike T-bet and GATA-3, c-Maf
expression is not regulated by cytokines, but rather bydriks et al., 1999; Ting et al., 1996). By performing a
representational difference analysis and studying the signals stemming from TCR. In vitro, c-Maf is an ex-
tremely potent transactivator of the IL-4 gene via itstranscriptional regulation of IL-5, Zheng et al. and Ray
and colleagues discovered that GATA-3 was almost ex- binding to a MARE site immediately 5 of the TATA box
in the proximal IL-4 promoter, and can confer the abilityclusively expressed in mature Th2 cells, but not in ma-
ture Th1 cells (Zhang et al., 1997; Zheng and Flavell, to produce endogenous IL-4 upon nonproducer cells
(Ho et al., 1996). The functions of c-Maf were confirmed1997). Naive Th cells express negligible levels of
GATA-3, which is rapidly induced in Th cells upon stimu- by in vivo studies. c-Maf overexpressor transgenic mice
had higher serum levels of IgE and IgG1, two IL-4-lation under Th2 skewing conditions. Once induced,
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dependent immunoglobulin isotypes, and Th cells de- hours after encountering antigen, developing Th cells
stochastically expressed IFN- in a monoallelic fashionrived from c-Maf transgenic mice spontaneously devel-
oped into Th2 cells in vitro (Ho et al., 1998). This shift even in the absence of Stat4 signaling (Mullen et al.,
2001). In addition, the initial induction of T-bet in naivein the Th1/Th2 balance toward the Th2 compartment
afforded substantial protection from disease in two sep- Th cells upon stimulation is independent of the IL-12/
Stat4 signal pathway, which actually provides a selec-arate models of autoimmune diabetes (Pauza et al.,
2001). Conversely, mice rendered deficient in c-Maf tive advantage for IFN--producing cells by enhancing
their proliferation and survival. Thus, the modest induc-have defects in mounting Th2 immune responses in vivo
with a spontaneous bias of Thp differentiation to the Th1 tion of T-bet by IL-12/Stat4 may simply reflect better
survival of T-bet-expressing cells. While these data arelineage (Kim et al., 1999). Interestingly, in the presence of
exogenous IL-4, c-Maf-deficient (c-Maf/) Th cells can consistent with a selection model, they do not exclude
a concurrent instructive mechanism for Th1 differentia-develop into Th2 cells that produce normal levels of
the Th2 cytokines IL-5, IL-10, and IL-13, although the tion. Of note, IFN--receptor-deficient Th cells are un-
able to develop into IFN--producing Th1 cells evenproduction of IL-4 by c-Maf/ Th2 cells remains se-
verely impaired. Taken together, these results demon- under optimal conditions, suggesting that the IFN- sig-
nal is at least as important as the IL-12/Stat4 signal forstrate that c-Maf is an IL-4-gene-specific transactivator,
and that c-Maf and GATA-3 promote the differentiation Th1 cell development (Zhang et al., 2001). Indeed, IFN-
is a very potent inducer of T-bet expression (Lighvaniof Th2 cells by distinct but complementary mechanisms.
We can conclude that expression of IL-4 requires both et al., 2001). Thus, the induction of T-bet by IFN-/Stat1
in developing Th1 cells is analogous to that of GATA-3c-Maf and GATA-3, but that the cell-type specificity of
other Th2 cytokines, such as IL-5 and IL-13, appears to by IL-4/Stat6 in developing Th2 cells, and strongly sup-
ports an instructive model of Th differentiation. It willmainly depend on GATA-3. However, the failure to fully
redirect polarized Th1 cells into the Th2 lineage by the be important to test whether Stat1/ Thp cells retain
the capacity to secrete IFN-, and if so, to delineate theprovision of both GATA-3 and c-Maf (Kishikawa et al.,
2001), in contrast to the actions of T-bet in accomplish- signaling pathways that account for such expression.
ing the reverse task, raises the intriguing possibility that
there are other yet-to-be-discovered factors necessary What Factors Account for Stat6-Independent Th2
for complete Th2 lineage commitment. Cell Differentiation?
While a tremendous amount of progress in under- It has been convincingly demonstrated that Stat6 is es-
standing the transcriptional regulation of Th cell differ- sential for maximal Th2 differentiation in vitro (Kaplan
entiation has occurred, there are several important et al., 1996; Shimoda et al., 1996; Takeda et al., 1996).
questions that remain unanswered, and many new ques- Stat6/ Th cells, generated by in vitro differentiation
tions raised by the recent discoveries. We consider under Th2 skewing conditions, produced very small
some of these below. amounts of Th2 cytokines. In vivo Th2 immune re-
sponses, however, can still be elicited in Stat6/ ani-
mals, and Th2 cells derived from Stat6/ mice expressSelection/Stochastic versus Instructive—Which
Is the Correct Model of Th Differentiation? high levels of GATA-3 and produce normal levels of Th2
cytokines (Finkelman et al., 2000; Jankovic et al., 2000;Our current understanding of the transcriptional regula-
tion of Th cell differentiation favors the notion that lin- Ouyang et al., 2000). These results imply the presence of
Stat6-independent, nonautonomous pathways for Th2eage determination of Th cells follows an instructive
model, but this is still very much an unsettled question cell differentiation, although the nature and composition
of these pathways remain unknown. One clue came fromthat will require further work. In this model, signals
downstream of IL-12/IFN- or IL-4 directly induce the studies on Bcl-6-deficient (Bcl-6/) mice. Bcl-6 is a
zinc finger protein that belongs to the POZ family ofexpression of lineage-determining transcription factors,
T-bet or GATA-3, and subsequently drive Th cell differ- transcription repressors, and mutation or translocation
of Bcl-6 is commonly found in diffuse large cell B lym-entiation along the Th1 or Th2 pathway, respectively.
This model is supported by several observations. (1) phoma (Staudt et al., 1999). Strikingly, Bcl-6/ mice
spontaneously develop multiorgan inflammation char-Newly committed Th1 cells can be forced to produce
IL-4 when restimulated in the presence of exogenous acterized by marked infiltration of Th2 cells, eosinophils,
and IgE-bearing B cells (Dent et al., 1997; Ye et al.,IL-4 (Farrar et al., 2001). (2) GATA-3 is rapidly induced
in naive Th cells when stimulated in the presence of IL-4 1997). Th cells isolated from Bcl-6/ mice produce very
high levels of Th2 cytokines in a cell-autonomous fash-in vitro, but very little induction of GATA-3 is observed
in Stat6/ Th cells (Ouyang et al., 1998). (3) Ectopic ion, however, the enhanced in vitro Th2 differentiation
was completely reversed in the absence of Stat6 (Harrisexpression of GATA-3 allows developing Stat6/ Th1
cells to secrete Th2 cytokines (Ouyang et al., 2000). et al., 1999). Therefore, Bcl-6 negatively regulates the
differentiation of Th2 cells at least partly via a Stat6-Similarly, overexpression of T-bet can force terminally
committed Th2 cells to display a Th1 cell phenotype dependent mechanism. Surprisingly, Bcl-6/Stat6/
mice still develop the lethal Th2 inflammatory response(Szabo et al., 2000). However, several papers have sug-
gested that the induction of GATA-3 by IL-4 is actually in vivo, and Th cells directly harvested from the inflamed
organs continued to produce Th2 cytokines at levelsdue to an absence of IL-12 (Ouyang et al., 2000, 1998;
Mullen et al., 2001). comparable to those of Bcl-6 / animals (Dent et al.,
1998). This surprising phenotype might well be ex-The instructive model was recently challenged by Mul-
len et al., who presented data demonstrating that, within plained by the Stat6-independent, nonautonomous Th2
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pathway, which is also augmented by the absence of deficient Th cells expressed substantially lower levels
of GATA-3 even under Th2 skewing conditions. Further-Bcl-6 in vivo.
These data raise an important and still unanswered more, inhibition of NF-B translocation by a synthetic
peptide, containing a signal sequence of Kaposi’s fibro-question in this field. What is the factor and from what
cell type does it come, that initiates differentiation along blast growth factor and the nuclear localization se-
quence of the p50 subunit, during the differentiation ofthe Th2 pathway in vivo? Is this factor IL-4 itself working
via the Stat6-dependent pathway, and if so, from what Th2 cells almost completely abolished the induction of
GATA-3 and the production of Th2 cytokines. Somewhatcell is it secreted? It has been suggested that NK T cells,
Thp cells themselves, or a non-T, non-B cell may be the unexpectedly, blockade of NF-B translocation had no
effect on the expression of GATA-3 and the productioninitial source of IL-4. The strongest evidence has been
marshaled for the Thp itself being the source of IL-4, of cytokines in mature effector Th2 cells. These results
imply that GATA-3 might be a downstream target gene ofperhaps arising spontaneously as in the stochastic
model of Th differentiation (Noben-Trauth et al., 2000). p50 in developing Th2 cells and that the transcriptional
regulation of GATA-3 might vary at different stages ofAnother possibility is that some other factor, produced
by non-Th cells, initiates the Th2 response by a Stat6- Th cell development.
The Polycomb group of genes was originally identifiedindependent mechanism. Here, we return to clues pro-
vided by the phenotype of the Bcl-6/ mice. By generat- in Drosphila as transcriptional repressors. Many Poly-
comb members have mammalian homologs, which areing a series of mixed chimeric animals, Toney et al.
(2002) showed that the Th2 inflammatory responses involved in the regulation of Hox gene expression (van
Lohuizen, 1999). mel-18 is one of the mammalian homo-seen in Bcl-6/ mice appeared to be mediated by
non-B, non-T cells. Recently, it was discovered that the logs. Unexpectedly, mel-18-deficient (mel-18/) mice
had moderate reductions in numbers of thymocytes andexpression of the chemokine MCP-1 in macrophages
was negatively regulated by Bcl-6 at the level of tran- peripheral T cells, and exhibited a striking impairment
in Th2 immune responses (Kimura et al., 2001). mel-scription (Toney et al., 2000). Earlier work demonstrated
that the chemokine MCP-1 promoted Th2 differentiation 18/ Th2 cells, generated by in vitro differentiation,
produced significantly lower levels of Th2 cytokines. Inas MCP-1-deficient mice displayed defects in Th2 im-
mune responses in vivo (Gu et al., 2000). Taken together, addition, antigen-induced IgG1 production and Nippo-
strongylus-induced eosinophilia were attenuated in mel-these results suggest a model in which Bcl-6 attenuates
the differentiation of Th2 cells by inhibiting the produc- 18/ mice. Interestingly, mel-18/ Th2 cells expressed
GATA-3 at much lower levels than wild-type Th2 cellstion of MCP-1 by non-B, non-T cells. This putative Stat6-
independent pathway for Th2 cell differentiation remains despite normal IL-4/Stat6 signaling (Kimura et al., 2001).
It remains unanswered whether the lower levels ofto be confirmed.
GATA-3 in mel-18/ Th2 cells are the cause or the result
of defective Th2 cell differentiation. If mel-18 is essentialHow Is the Expression of GATA-3 and T-bet
for optimal GATA-3 induction, it will be important toRegulated at the Transcriptional Level?
know if overexpression of mel-18, either in the absenceIf GATA-3 is essential and sufficient for Th2 cell differen-
or the presence of IL-4/Stat6 signals, can induce thetiation, then induction of GATA-3, either by a Stat6-
expression of GATA-3 and subsequently promote Th2dependent or a Stat6-independent mechanism, should
cell differentiation.be the lineage-determining event for Th2 cells. Unfortu-
The expression of T-bet and GATA-3 is mutually exclu-nately, very little is known about the transcriptional regu-
sive during the priming of Th cells. This observationlation of GATA-3. As mentioned above, GATA-3 is a
raises the question whether T-bet and GATA-3 counter-T cell-specific transcription factor that is rapidly induced
regulate each other. Addressing this question requiresby IL-4/Stat6. Once induced, GATA-3 can undergo au-
identification and cloning of cell-type-specific promot-toactivation, a Stat6-independent process, to augment
ers of the T-bet and gata-3 genes, which are currentlyits expression. The cis-acting elements that are required
not available. Furthermore, there are very limited datafor T or Th2 cell-specific expression of the gata-3 gene
on the transcriptional regulation of T-bet. Thus far, inremain elusive. A YAC encompassing approximately 625
addition to TCR stimulation, IFN- is the most potentkb of the murine gata-3 locus failed to support the ex-
inducer of T-bet expression (Lighvani et al., 2001). Itpression of a reporter gene in thymi or lymphoid organs
remains unclear if there are other signaling pathways orin transgenic animals, indicating that cis-acting ele-
transcription factors, in addition to TCR and IFN-, thatments outside the 625 kb YAC are required to achieve
can induce the expression of T-bet.cell-type-specific expression of GATA-3 (Lakshmanan
et al., 1999). Even less is known about the transcription
factors, other than Stat6, that regulate the expression Is There Posttranslational Modulation
of GATA-3 and T-bet Activity?of GATA-3. Two recent reports provide some answers
to this question. The activity of the GATA-3 protein can also be modu-
lated by posttranslational mechanisms. For example, itThe transcription factor NF-B regulates the expres-
sion of many cytokine genes. Interestingly, mice ren- has been known for many years that an increase in
intracellular cyclic AMP enhances cytokine productiondered deficient in the p50 subunit of NF-B were resis-
tant to allergic airway inflammation, and were unable to by Th2 cells but has opposite effects on Th1 cytokines
(Munoz et al., 1990). This effect has recently been shownmount normal Th2 immune responses in both in vivo
and in vitro systems, whereas their Th1 responses were to be due to a specific activation of p38 MAP kinase in
Th2 cells by increased intracellular cAMP that resultsintact (Das et al., 2001). In addition, developing p50-
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in phosphorylation of GATA-3 (Chen et al., 2000). In 1997). In the nucleus, NFATs activate the expression
of multiple genes involved in the immune response toagreement with these results, p38-specific inhibitors di-
antigen, including those encoding cytokines and cellminish the transactivation capacity of GATA-3 in vitro.
surface receptors. In vitro, all NFAT members are capa-In addition to phosphorylation, mature GATA-3 proteins
ble of binding to a conserved sequence, originally identi-appear to be heavily acetylated (Yamagata et al., 2000).
fied in the IL-2 promoter (Durand et al., 1988; Shaw et al.,This may be the basis for the dominant-negative pheno-
1988). The global abolition of cytokine gene transcriptiontype of the KRR mutant of GATA-3, where the substitu-
that occurs in the presence of CsA indicates that NFATtion of the lysine-arginine-arginine (KRR) residues at
proteins also play important roles in regulating the tran-amino acid 305–307 with alanines (AAA) significantly
scription of multiple other cytokines including IL-4,diminishes GATA-3 acetylation. Despite these observa-
TNF, IFN-, and GM-CSF. Indeed, specific sequencestions, it remains unclear whether posttranslational modi-
within the IL-4 proximal promoter that are bound byfications of GATA-3 are functionally relevant in vivo.
NFAT proteins are critical for both the CsA sensitivityIn contrast to GATA-3, very little is known about the
and inducibility of IL-4 (Todd et al., 1993). In vitro, NFATposttranslational modification of T-bet, although it is
proteins clearly function as transcription activators.intriguing that T-bet contains several potential tyrosine
The in vivo role of NFAT proteins as evidenced by thephosphorylation sites (Szabo et al., 2000), a feature
phenotype of mice that lack one or more NFAT familyrarely found in transcription factors, the most notable
members, appears, however, to be very complex, andexception being the Stat proteins.
still not satisfactorily explained. For example, as de-In addition to posttranslational modification, the activ-
scribed below, although NFATc1 (NFATc, NFAT2),ities of GATA-3 can be modulated by physical interaction
NFATc2 (NFATp, NFAT1), and NFATc3 (NFAT4, NFATx)with other nuclear proteins. A cDNA encoding a
are present in both Th subsets, they nevertheless havelymphoid-specific GATA-3 interacting protein, ROG,
profound effects on cytokine gene transcription that canwas recently isolated and shown to attenuate the activi-
be subset selective.ties of GATA-3 and repress the production of cytokines
NFATc1-deficient (NFATc1/) Th cells, generated byby Th2 clones in vitro (Miaw et al., 2000). More recently,
reconstitution of RAG-2-deficient mice, proliferatedFOG-1, a GATA-interacting multitype zinc finger protein
poorly in response to stimulation, and produced consid-enriched in hematopoietic cells, was found to be critical
erably lower levels of Th2, but not Th1 cytokines (Rangerfor the development of the T cell lineage. Forced expres-
et al., 1998a; Yoshida et al., 1998). Moreover, NFATc1sion of FOG-1 significantly repressed the transcriptional
and c2 doubly-deficient chimeras had a profound andactivity of GATA-3, the production of Th2 cytokines, and
global defect in cytokine secretion including IL-2, IL-3,the differentiation of Th2 cells in vitro (Zhou et al., 2001).
IL-4, IL-5, IFN-, TNF, and GM-CSF (Peng et al., 2001).However, the roles of ROG and FOG-1 in modulating
These results are in agreement with the expected func-the activity of GATA-3 and, subsequently, the differentia-
tions of NFAT proteins as transcription activators de-tion of Th cells in vivo remain unclear. The generation
duced from in vitro experiments. However, other NFATand analysis of mice lacking ROG and FOG-1-in the
family members have more complicated functions inlymphoid system should prove informative.
vivo that cannot be explained by their ability to control
cytokine genes. Thus, NFATc2-deficient (NFATc2/)
How Do Members of the NFAT Family
animals unexpectedly developed a mild age-dependent
of Transciption Factors Control lymphoproliferative disorder, accompanied by modest
Th Differentiation? increases of Th2 cytokines upon repeated stimulation
We have focused so far on the three factors, T-bet, (Hodge et al., 1996b; Xanthoudakis et al., 1996). Further,
GATA-3, and c-Maf, that are themselves expressed in NFATc2/ Th2 cells maintained the expression of IL-4
a subset-selective manner. However, there are several transcripts longer relative to wild-type. Although
other factors which, although not tissue specific, never- NFATc3-deficient (NFATc3/) mice do not display de-
theless play critical roles in Th differentiation. The most fects in cytokine production (Oukka et al., 1998), mice
important of these are members of the Stat and NFAT lacking both NFATc2 and NFATc3 had a very striking
family of transcription factors. We will leave it to a com- phenotype characterized by excessive overproduction
panion review in this issue to cover the functions of the of IL-4 and other Th2 cytokines, highly elevated IgE and
Stat family in Th differentiation and will focus here on IgG1 titers and severe allergic and inflammatory disease
what is known about the NFATs. in the skin and lung (Ranger et al., 1998b). In addition,
Many questions still remain about the function of the the absence of these two NFAT members rendered acti-
nuclear factor of activated T cells (NFAT) family of tran- vated Th cells resistant to activation-induced cell death.
scription factors (NFATc1, NFATc2, NFATc3, and The combination of hyperproliferation and resistance to
NFATc4) in regulating the Th1/Th2 balance. NFAT pro- AICD resulted in a severe lymphoproliferative disorder,
teins share a conserved Rel homology domain distantly a phenotype that persisted even in the absence of IL-4
related to the NF-B family, but are otherwise distinct (Rengarajan et al., 2002). The increased proliferation and
from each other in both sequence and tissue distribu- Th2 bias occurs very early in differentiation as naive
tion, raising the possibility that they possess both unique NFATc2/NFATc3/ Thp intrinsically differentiate into
and overlapping functions. These calcium-regulated the Th2 lineage. This may be related to the recently
proteins reside in the cytosol and upon stimulation described function of NFATc2 and NFATc3 in setting
through TCR undergo dephosphorylation by calcineurin, the threshold of responsiveness of naive Thp to signals
and translocate into the nucleus, a process inhibited by transmitted via the TCR, by regulating their activation
threshold and subsequent cell division profiles (Ren-the immunosuppressant cyclosporin A (CsA) (Rao et al.,
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garajan et al., 2002). Interestingly, this hyperresponsive- Interplay of Th-Selective and Nonselective
Factorsness of naive Thp to TCR-mediated activation occurs
without coengagement of CD28, raising the possibility Transcription factors typically influence each other ei-
ther directly via protein-protein interaction or indirectlythat NFATs lie downstream of or parallel to signaling
pathways stemming from coreceptor molecules in addi- via cross-regulation. The array of transcription factors
present in Th cells makes assembling a comprehensibletion to their positioning downstream of the TCR.
These studies suggest that NFATc2 and NFATc3 have picture of this pathway a daunting task and one that
remains very much to be determined. However, we offerinhibitory functions in vivo and may regulate negative
feedback mechanisms that ultimately control Th2 polar- the following version, shown schematically in Figure 3.
We will assume that the two types of receptors on theization. The NFAT target genes that account for this
negative feedback remain unknown, although the re- naive Thp cell that are most critical for Th differentiation
are the TCR, and the cytokine receptors, IFN- and IL-4.pressive effect is probably achieved by a mechanism not
involving IL-4/Stat6. It thus provides another example, in The encounter of a Thp cell with specialized subsets of
dendritic cells that express an MHC/antigen complexaddition to Bcl-6, of IL-4/Stat6 independent mecha-
nisms for Th2 cell differentiation. One means by which will activate the TCR signaling complex, resulting in acti-
vation of the NFAT and c-Maf transcription factors.NFATc2 and NFATc3 may inhibit Th2 differentiation is
by regulating the access of GATA-3 to the IL-4-IL-5-IL- These transcription factors can bind to cytokine promot-
ers leading to the production of multiple cytokines, per-13 locus, since both GATA-3 and NFATc2 bind to an
enhancer region 3 of the IL-4 gene in Th2 but not in haps especially IL-4. At the same time, small amounts
of IFN- and IL-4 cytokines produced stochastically inTh1 cells (Agarwal et al., 2000). In the absence of NFATc2
and NFATc3, GATA-3 may gain unrestricted access to the Thp cell or provoked by TCR-activated NFATs/c-maf
will next induce, via Stat 1 or Stat6, the expression ofthis locus, leading to excessive transcription of Th2 cy-
tokines. Alternatively, the role of NFATc2 and NFATc3 T-bet and GATA-3 respectively. T-bet then drives the
transcription of IFN-while GATA-3 drives the transcrip-in regulating the “strength of signal” perceived from
membrane receptors may intersect with as yet unidenti- tion of IL-4 in positive feedback loops. T-bet and GATA-3
simultaneously inhibit the expression of the cytokines offied genes that control Th1/Th2 cytokine production.
Taken together, the analysis of NFAT-deficient mice the opposing subset, thus initiating a negative feedback
loop as well. IFN- also causes upregulation of the IL-clearly demonstrates that each NFAT member has both
unique and redundant functions in vivo. We can con- 12R2 chain (Szabo et al., 1997), thus making the naive
Thp susceptible to IL-12, the potent Th1-differentiationclude that NFATc1 is essential for normal Th2 re-
sponses, whereas NFATc2 and NFATc3 function as neg- factor secreted by dendritic cells.
Putting this all together leads us to the followingative regulators of Th2 cell differentiation. It still remains
unclear how the functional dichotomy of NFAT proteins schema (Figure 3). The expression of T-bet and GATA-3
during Th differentiation are striking mirror images, andis achieved given the fact that all NFAT members per-
form similarly in vitro. An attractive explanation is that these factors are similar in their ability to induce one
lineage while simultaneously repressing the opposingNFATc2 and NFATc3, but not NFATc1, might induce one
or a group of negative regulators for Th2 cell differentia- lineage. Thus, it is highly likely that T-bet and GATA-3
are the master regulators of Th lineage commitment.tion. Such negative regulators have yet to be identified.
An alternative explanation is that the functions of T-bet lies downstream of IFN-/Stat1, the major inducer
of Th1 differentiation, while GATA-3 is activated by IL-4/NFAT proteins might be modulated by proteins with
which they physically interact. One such interacting pro- Stat6, the critical Th2-inducing cytokine. The NFATs and
c-Maf are induced by TCR rather than cytokine signals,tein is NIP45, which was originally cloned by its ability to
interact with the Rel homology domain of NFAT proteins and the NFATs act both to directly drive the transcription
of cytokines, and to set the threshold of TCR activation.(Hodge et al., 1996a). NIP45 does not contain any known
functional domains found in classical transcription fac- This threshold controls the Th1/Th2 balance by control-
ling the “strength of signal.” One question immediatelytors and, by itself does not transactivate cytokine pro-
moters. However, NIP45 substantially augments NFAT- comes to mind. What determines which factor, T-bet or
GATA-3, wins the race in any given Thp? We do notdependent IL-4 gene transcription. Provision of NIP45,
NFATc2, and c-Maf confers on non-Th2 cells the ability have the answer to this question but can engage in
some speculation. It is tempting to suggest that T-betto produce IL-4 at levels comparable to those of Th2
cells, suggesting that NIP45 might act as a coactivator and GATA-3 regulate each other with T-bet blocking
GATA-3 expression during Th1 differentiation andof NFAT for IL-4 gene transcription. However, NIP45 can
also interact with TRAF2 to repress the production of GATA-3 repressing T-bet expression during Th2 devel-
opment. Indeed, cytokine gene expression may moreIL-4, a finding consistent with the increased levels of Th2
cytokines found in mice carrying a dominant-negative generally reflect a balance between repressors and acti-
vators as demonstrated by the known functions of T-betTRAF2, which can not interact with NIP45 (Lieberson et
al., 2001). These observations indicate that NIP45 can in repressing Th2 programs (Szabo et al., 2000), while
GATA-3 and c-Maf act as Th1 repressors. (Ho et al.,function both as a coactivator of NFAT and IL-4, and
also as an inhibitor of NFAT-driven IL-4 production by 1998; Ouyang et al., 1998). Another relevant example is
the Stats. Mice lacking both Stat4 and Stat6 mount aa TRAF2-dependent mechanism. Thus, the function of
NFATs in regulating cytokine production can be modu- Th1 response that exceeds that seen in Stat6/ mice,
suggesting that Stat6 may act as a repressor in Th1lated in both positive and negative fashion by their inter-
action with other proteins by mechanisms yet to be cells (Kaplan et al., 1998). The relative predominance of
T-bet and GATA-3 elicited by any given pathogen mayelucidated.
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Figure 3. Schematic Diagram of Signaling and Transcriptional Events that Lead to the Differentiation of Th1 and Th2 Cells
thus ultimately determine the lineage choice of any given matin in committed Th cells, presumably as a way to
stabilize the effector Th cell phenotype (Grogan et al.,Thp. It is intriguing to speculate that the interaction of
the pathogen/MHC complex with TCR acts through indi- 2001). An important role for epigenetic inheritance of
the IL-4 gene has also been described. Thus, monoallelicvidual NFAT family members to control T-bet or GATA-3
expression, thus placing these factors both upstream/ IL-4 expression, reminiscent of that observed for immu-
noglobulin and T cell receptor genes, has been de-downstream and parallel to each other.
scribed in T cell clones derived from heterozygous mice
(Bix and Locksley, 1998) and in mice deliberately madeIs the Th2 Locus Coordinately Regulated?
heterozygous by insertion of reporter genes into the IL-4Epigenetic Control of Cytokine Loci
locus (Hu-Li et al., 2001; Riviere et al., 1998). A role forIn addition to regulation by transcription factors, it is
cytosine methylation in the regulation of the IL-4 geneincreasingly apparent that expression of cytokine genes
has also been invoked, as hypomethylation of severalis also subject to epigenetic control. IL-4, IL-5, and IL-
CpGs in the second intron of the IL-4 gene only in Th2 but13 reside at the same chromosomal location in both
not Th1 clones was observed during the differentiativeman and mouse with the IL-4 gene only 10 kb away
process (Bird et al., 1998).from the IL-13 gene. During Th2 differentiation, the Th2
Is There a Locus Control Region for the Th2cytokine locus undergoes a remodeling process which
Cytokine Cluster?results in the appearance of several Th2 cell-specific
Given the physical proximity and concordant remodel-DNaseI hypersensitivity sites (Agarwal and Rao, 1998).
ing of Th2 cytokine genes, it has been postulated thatGATA-3 is sufficient to induce the remodeling of this
a locus control region might regulate the Th2 locus,locus in a Stat6-independent fashion (Ouyang et al.,
although its nature and location remain elusive. By com-2000). A similar remodeling process is present at the
paring mouse and human sequences of noncoding DNAIFN- locus during the differentiation of Th1 cells (Agar-
in the Th2 cytokine locus, several homologous regionswal and Rao, 1998; Young et al., 1994). The functional
were identified. One of these stretches of DNA, calledsignificance of epigenetic control was highlighted by a
CNS-1, is located in the intergenic region between therecent report. Both IFN- and IL-4 genes are positioned
IL-4 and the IL-13 genes (Loots et al., 2000). A 425 kbapart from heterochromatin in naive Th cells, which are
YAC transgenic construct containing the human Th2capable of transcribing both genes simultaneously
cytokine locus, including CNS-1, was sufficient to sup-within hours after stimulation in a Stat4-/Stat6-indepen-
port the expression of human IL-4, IL-5, and IL-13 indent manner. In contrast, the silenced cytokine alleles
are repositioned to transcriptionally inactive heterochro- transgenic murine Th2 cells. In contrast, deletion of
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CNS-1 from the transgenic construct substantially re- Conclusion
We know a great deal now about the events that occurduced the production of human Th2 cytokines. In an-
other transgenic model, however, CNS-1 alone was not inside the nucleus of an uncommitted T helper precursor
cell as it embarks on its journey toward differentiationsufficient to dictate Th2 cell specificity. Instead, CNS-1
functioned as a subset nonspecific enhancer (Lee et al., and commitment. Like other stem cells, the Thp has
choices to make which are governed by competing stim-2001). Furthermore, deletion of CNS-1 by homologous
recombination substantially reduced the production of uli in its environment. These stimuli engage membrane
receptors to activate signaling pathways, which in turnTh2 cytokines but did not completely abrogate the differ-
entiation of Th2 cells (Mohrs et al., 2001). Taken to- activate a limited number of both tissue-specific and
non-tissue-specific transcription factors. While we havegether, these results indicate that the concerted action
of multiple cis-acting elements, including CNS-1, within learned much about the mechanism of action of the
known transcription factors, there is more still to learn.the 425 kb YAC, rather than a single locus control region,
is required to achieve coordinate expression of IL-4, It is likely, too, that there are additional important regula-
tory proteins whose sequences lie peacefully undiscov-IL-5, and IL-13 in a Th2 cell-specific manner. Of note,
multiple potential GATA binding sites have been identi- ered in the various genome databases. Furthermore, in
contrast to our increasing knowledge about the geneticfied along the Th2 cytokine locus, and some of these
sites appear to be functional in vitro (Ranganath et al., programs executed by transcription factors, we know
exceedingly little about the complicated signals trans-1998). It remains unclear if the remodeling process pre-
cedes or is the result of the binding of GATA-3 to these mitted from membrane to nucleus. How does the Thp
cell integrate and translate the plethora of signals stem-sites, although GATA-3 would appear to be genetically
upstream of the formation of Th2-specific hypersensi- ming from membrane receptors into the activation of
select transcription factors? The discovery of an “immu-tive sites (Lee et al., 2000 Ouyang et al., 2000).
nologic synapse” has led to the recent demonstration
of distinct patterns of microdomain partitioning in differ-What Factors Account for Cytokine Production
entiated Th1 and Th2 cells, an exciting first step (Bala-by Cytotoxic T Cells?
muth et al., 2001). Examination of the membrane com-The Th1/Th2 paradigm extends to immune system cells
partmentalization into lipid rafts in the naive Thp as itother than the helper T lymphocyte. The cytotoxic CD8
first encounters antigen-presenting cells may lead toT cell, NK cell, and  T cell can also be divided into two
a molecular definition of the earliest stages of lineagesubsets called Tc1/Tc2, NK1/NK2, and 1/2, which
commitment. Lessons learned from the analysis of de-secrete type 1 or type 2 cytokines (Mosmann and Sad,
velopmental and differentiative processes in other organ1996; Peritti et al., 1998). For example, Tc1 cells express
systems and in other organisms may also provide valu-T-bet and produce IFN-, whereas Tc2 cells secrete IL-4
able clues.and IL-13. One might have predicted that the molecular
machinery that works so well for CD4 cells would be
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